These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36854551)

  • 1. [Interferon-related gene array in predicting the efficacy of interferon therapy in chronic hepatitis B].
    Wang J; Lu J; Zhou C; Du L; Tang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Feb; 40(1):79-86. PubMed ID: 36854551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
    Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
    J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between the suppressor of cytokine signaling 3 expression and antiviral efficacy of nucleos(t)ide and interferon alpha therapy for chronic hepatitis B].
    Wang YL; Wu WY; You J; Yan WM; Luo XP; Ning Q; Han MF
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):27-32. PubMed ID: 30685920
    [No Abstract]   [Full Text] [Related]  

  • 4. Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus.
    Xiao C; Qin B; Chen L; Liu H; Zhu Y; Lu X
    J Viral Hepat; 2012 Feb; 19(2):e1-10. PubMed ID: 22239505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-α-2a antiviral therapy.
    Deng G; Ge J; Liu C; Pang J; Huang Z; Peng J; Sun J; Hou J; Zhang X
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):386-398. PubMed ID: 28236535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of anti-interferon antibodies is not associated with non-response to pegylated interferon treatment in chronic hepatitis B.
    Arends P; van der Eijk AA; Sonneveld MJ; Hansen BE; Janssen HL; Haagmans BL
    Antivir Ther; 2014; 19(4):423-7. PubMed ID: 24296674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapy.
    Hu X; Luo H; Tan G; Li Y; Qin B
    BMC Gastroenterol; 2023 May; 23(1):163. PubMed ID: 37208599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infection.
    Han M; Li Y; Wu W; Zhang Y; Yan W; Luo X; Ning Q
    Antiviral Res; 2017 Nov; 147():75-85. PubMed ID: 28988797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal Interferon-Induced Transmembrane Protein 2 Transmitted to Dendritic Cells Inhibits Interferon Alpha Pathway Activation and Blocks Anti-Hepatitis B Virus Efficacy of Exogenous Interferon Alpha.
    Shi Y; Du L; Lv D; Li H; Shang J; Lu J; Zhou L; Bai L; Tang H
    Hepatology; 2019 Jun; 69(6):2396-2413. PubMed ID: 30723923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
    Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
    Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of interferon alpha-2b versus pegylated interferon alpha-2a monotherapy in children with chronic hepatitis B: a real-life cohort study from Shanghai, China.
    Hu Y; Ye YZ; Ye LJ; Wang XH; Yu H
    World J Pediatr; 2019 Dec; 15(6):595-600. PubMed ID: 31487005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients.
    Liu YZ; Hou FQ; Ding P; Ren YY; Li SH; Wang GQ
    Virol J; 2012 Nov; 9():274. PubMed ID: 23158844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on pegylated interferon augments hepatitis B surface antigen clearance
    Wu FP; Yang Y; Li M; Liu YX; Li YP; Wang WJ; Shi JJ; Zhang X; Jia XL; Dang SS
    World J Gastroenterol; 2020 Apr; 26(13):1525-1539. PubMed ID: 32308352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.
    Holmes JA; Nguyen T; Ratnam D; Heerasing NM; Tehan JV; Bonanzinga S; Dev A; Bell S; Pianko S; Chen R; Visvanathan K; Hammond R; Iser D; Rusli F; Sievert W; Desmond PV; Bowden DS; Thompson AJ
    J Gastroenterol Hepatol; 2013 May; 28(5):861-6. PubMed ID: 23301835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of pegylated-interferon alpha-2a treatment in patients with HBeAg-positive chronic hepatitis B and partial viral response to nucleoside analogue therapy].
    Li MH; Hu LP; Zhang L; Lu Y; Shen G; Wu SL; Chang M; Mu CQ; Wu YZ; Yang M; Song SJ; Zhang SF; Hua WH; Xie Y; Cheng J; Xu DZ
    Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):826-31. PubMed ID: 26743242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insufficient immunity led to virologic breakthrough in NAs-treated chronic hepatitis B patients switching to Peg-IFN-ɑ.
    Huang D; Yan W; Han M; Yuan W; Wang P; Chen Y; Wan X; Luo X; Wu D; Ning Q
    Antiviral Res; 2022 Jan; 197():105220. PubMed ID: 34848218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIG-I enhances interferon-α response by promoting antiviral protein expression in patients with chronic hepatitis B.
    Wu S; Lin J; Fu Y; Ou Q
    Antivir Ther; 2018; 23(7):575-583. PubMed ID: 29790851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of interferon activity-associated soluble molecules by appendicitis and appendectomy limits colitis-identification of novel anti-colitic targets.
    Cheluvappa R; Eri R; Luo AS; Grimm MC
    J Interferon Cytokine Res; 2015 Feb; 35(2):108-15. PubMed ID: 25243802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B.
    He Y; Zhou Y; Wang H; Peng X; Chang Y; Hu P; Ren H; Xu H
    BMC Pediatr; 2022 Jul; 22(1):426. PubMed ID: 35854256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin expression levels involve efficacy of pegylated interferon-α treatment in hepatitis B-infected liver.
    Jia J; Zhang Y; Zhang H; Chen Z; Chen L; Zhou Q; Lv X; Wang Q
    Int Immunopharmacol; 2022 Jun; 107():108641. PubMed ID: 35217337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.